Evaluation of cfDNA mutation spectrum in metastatic breast cancer

被引：0
|
作者：
Shibayama, Tomoko [1 ]
Kobayashi, Takayuki [1 ]
Ohno, Shinji [1 ]
Ito, Yoshinori [1 ]
Ueno, Takayuki [1 ]
Ono, Makiko [2 ]
Takahashi, Shunji [2 ]
Siew-Kee, Low [3 ]
机构：
[1] Canc Inst Hosp, Breast Oncol Ctr, Tokyo, Japan
[2] Canc Inst Hosp, Dept Med Oncol, Tokyo, Japan
[3] JFCR, Canc Precis Med Ctr, Tokyo, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J-2016
引用
收藏
页码：707 / 707
页数：1
相关论文
共 50 条
  • [41] The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies
    Lindsay Angus
    Marcel Smid
    Saskia M. Wilting
    Job van Riet
    Arne Van Hoeck
    Luan Nguyen
    Serena Nik-Zainal
    Tessa G. Steenbruggen
    Vivianne C. G. Tjan-Heijnen
    Mariette Labots
    Johanna M. G. H. van Riel
    Haiko J. Bloemendal
    Neeltje Steeghs
    Martijn P. Lolkema
    Emile E. Voest
    Harmen J. G. van de Werken
    Agnes Jager
    Edwin Cuppen
    Stefan Sleijfer
    John W. M. Martens
    Nature Genetics, 2019, 51 : 1450 - 1458
  • [42] ARID1A Mutation in Metastatic Breast Cancer: A Potential Therapeutic Target
    Cheng, Xuan
    Zhao, Jian-Xiong
    Dong, Feng
    Cao, Xu-Chen
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [43] Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancer
    Silva, Romina
    Moran, Bruce
    Baird, Anne-Marie
    O'Rourke, Colm J.
    Finn, Stephen P.
    McDermott, Ray
    Watson, William
    Gallagher, William M.
    Brennan, Donal J.
    Perry, Antoinette S.
    CLINICAL EPIGENETICS, 2021, 13 (01)
  • [44] Pan-genome cfDNA methylation analysis of metastatic prostate cancer
    Wu, A.
    Cremaschi, P.
    Wetterskog, D.
    Conteduca, V.
    Franceschini, G. M.
    Gonzalez-Billalebeita, E.
    Giorgi, U. D.
    Demichelis, F.
    Lise, S.
    Attard, G.
    ANNALS OF ONCOLOGY, 2019, 30
  • [45] Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancer
    Romina Silva
    Bruce Moran
    Anne-Marie Baird
    Colm J. O’Rourke
    Stephen P. Finn
    Ray McDermott
    William Watson
    William M. Gallagher
    Donal J. Brennan
    Antoinette S. Perry
    Clinical Epigenetics, 2021, 13
  • [46] Assessment of cfDNA in patients with metastatic colorectal cancer treated with cetuximab monotherapy
    Angus, L.
    van Helden, E. J.
    van Es, S. C.
    Boon, E.
    van Herpen, C. M. L.
    de Groot, D. J.
    de Vries, E. G. E.
    van Oordt, C. W. Menke-van der Houven
    Sleijfer, S.
    Verheul, H. M.
    Jansen, M. P. H. M.
    ANNALS OF ONCOLOGY, 2018, 29 : 50 - 50
  • [47] EVALUATION OF THE HEALTHCARE COSTS AND UTILIZATION OF PATIENTS WITH METASTATIC BREAST CANCER
    Ko, Y.
    Chen, H.
    Chen, J.
    Chiang, S.
    Lin, Y.
    VALUE IN HEALTH, 2018, 21 : S13 - S13
  • [48] EVALUATION OF TAMOXIFEN IN CHEMOTHERAPY RESISTANT METASTATIC BREAST-CANCER
    LEGHA, SS
    BUZDAR, AU
    BENJAMIN, RS
    BURGESS, MA
    BLUMENSCHEIN, GR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 334 - 334
  • [49] EVALUATION OF DEPRESSION AND ANXIETY IN YOUNG WOMEN WITH METASTATIC BREAST CANCER
    Mehmood, Tahir
    BREAST, 2019, 48 : S64 - S64
  • [50] Phase II evaluation of thalidomide in patients with metastatic breast cancer
    Baidas, SM
    Winer, EP
    Fleming, GF
    Harris, L
    Pluda, JM
    Crawford, JG
    Yamauchi, H
    Isaacs, C
    Hanfelt, J
    Tefft, M
    Flockhart, D
    Johnson, MD
    Hawkins, MJ
    Lippman, ME
    Hayes, DF
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (14) : 2710 - 2717
12345